A conversation with Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, which is a member of the Big Ten Cancer Research Consortium (CRC):
Having integrated last year with Rutgers, The State University of New Jersey, Rutgers Cancer Institute of New Jersey is no stranger to collaboration when it comes to advancing scientific discoveries and developing innovative new treatment options for cancer patients. But as Dr. Robert S. DiPaola explains, being part of a consortium enables a wealth of expertise and resources to accomplish this very important mission.Read More
April 30, 2014: The Big Ten Cancer Research Consortium (Big Ten CRC) is accepting applications for executive officer. This is an exciting time for the consortium, with several clinical trial working groups (CTWGs) meeting regularly, three LOIs approved, and numerous concepts under discussion. The executive officer will be instrumental in the continued success of the Big Ten CRC, and the position offers a unique career opportunity for the candidate. Candidates must be faculty members at Big Ten CRC member institutions. Read More
April 21, 2014: A leading gastrointestinal cancer expert has joined the Indiana University Melvin and Bren Simon Cancer Center. Bert Howard O'Neil, M.D., has been named the inaugural Joseph W. and Jackie J. Cusick Professor of Oncology and a professor of medicine at the IU School of Medicine. He is also the Phase I director and director of the gastrointestinal cancer research program at the IU Simon Cancer Center, and he will represent the cancer center on the Big Ten Cancer Research Consortium steering committee. Read More
April 15, 2014: The Big Ten Cancer Research Consortium announces Zoe Holt, CCRP, will serve as senior project manager. Holt will provide project management for Big Ten CRC protocols as well as contribute to the continued growth of the consortium by providing administrative support for the meetings and activities of the steering committee and cancer center directors, overseeing the efforts to establish an expedited IRB process, and developing institutional relationships to support the consortium’s fundraising priorities. “I am thrilled to further support the Big Ten Cancer Research Consortium and look forward to working with such accomplished oncologists and prestigious academic research institutions,” said Holt. “Our work together holds great promise for furthering science and... Read More
April 8, 2014: The National Cancer Institute has renewed its designation of the Masonic Cancer Center, University of Minnesota, as a comprehensive cancer center after a highly competitive and rigorous process. The reviewers recommended support for the Masonic Cancer Center of nearly $20M over the next 5 years. Final funding levels are still being determined by the NCI. This is the fourth consecutive designation awarded to the Masonic Cancer Center, which is one of only two NCI-designated comprehensive cancer centers in the state of Minnesota and one of only 41 such centers nationwide. The NCI noted several high impact areas at the University of Minnesota, including cell-based therapies, tobacco control, cancer prevention and screening, the... Read More
March 25, 2014: Sarah Thayer, M.D., Ph.D., an internationally recognized physician-scientist from Harvard Medical School, will be joining the University of Nebraska Medical Center to lead cancer surgery efforts and have a significant leadership role in the Fred & Pamela Buffett Cancer Center. Thayer will start May 1 as associate director for clinical affairs and physician-in-chief for the Fred & Pamela Buffett Cancer Center. She also has been appointed Merle M. Musselman Centennial Professor of Surgery and chief of surgical oncology at UNMC. "This is a prominent example that the Fred & Pamela Buffett Cancer Center will attract the brightest minds in cancer care and... Read More
March 21, 2014:Rutgers University President Dr. Robert Barchi recently cited the Big Ten Cancer Research Consortium as an example of the academic collaboration that is possible between the Big Ten member institutions. "This consortium of world-class academic institutions will enable a collaborative approach to improving our understanding of cancer in the lab and our treatment of cancer in our hospitals," Barchi said in a letter to the Rutgers community. Read Dr. Barchi's letter. The Read More
Jan. 8, 2014: The Big Ten Cancer Research Consortium (Big Ten CRC) is actively seeking concepts for highly translational oncology trials that leverage the scientific and clinical expertise of Big Ten universities. The consortium is setting the goal to receive at least one new concept from each institution during 2014. Click here to download the Request for Application (Microsoft Word format). Once submitted, concepts will be discussed through a clinical trial working group mechanism. These disease-specific working groups are another way to increase collaboration across the Big Ten CRC institutions and provide an opportunity for senior investigators to mentor junior investigators throughout the development... Read More
Dec. 23, 2013:University of Nebraska Medical Center's Julie Vose, M.D., has been elected president of the American Society of Clinical Oncology (ASCO) for a one-year term beginning in June 2015. Vose will take office as president-elect during the ASCO annual meeting in Chicago in June 2014. "ASCO is a very diverse and multifaceted organization with so much to offer its membership," Vose said. "I am excited to serve the ASCO membership as president and to make a difference for oncology professionals and our patients." Vose cited the recent enhancements in the society's educational offerings, quality improvement, and broadened advocacy as areas where her experience and training can add to... Read More
Dec. 12, 2013: Representatives of the Big Ten Cancer Research Consortium (Big Ten CRC) institutions met recently in Chicago to discuss development of a collaborative IRB review process for Big Ten CRC studies. Participants focused on the benefits and challenges of a reciprocal deferral agreement, which would expedite the approval process for multi-site trials and avoid duplicate reviews at each site. Carol Pech, Ph.D., associate director of the Health Sciences Institutional Review Boards Office at the University of Wisconsin-Madison, presented a model of a working IRB collaboration, the Wisconsin IRB Consortium. Read More
Having integrated last year with Rutgers, The State University of New Jersey, Rutgers Cancer Institute of New Jersey is no stranger to collaboration when it comes to advancing scientific discoveries and developing innovative new treatment options for cancer patients. But as Dr. Robert S. DiPaola explains, being part of a consortium enables a wealth of expertise and resources to accomplish this very important mission. Read More
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube